×
Gepirone Extended-Release: New Evidence for Efficacy in the Treatment of Major Depressive Disorder PDF
$ 40.00
Gepirone Extended-Release: New Evidence for Efficacy in the Treatment of Major Depressive Disorder PDF quantity
$ 40.00
×
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF
$ 40.00
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF quantity
$ 40.00
×
An Open-Label, Flexible-Dose Study of Olanzapine in the Treatment of Trichotillomania PDF
$ 40.00
An Open-Label, Flexible-Dose Study of Olanzapine in the Treatment of Trichotillomania PDF quantity
$ 40.00
×
Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials PDF
$ 40.00
Antidepressants for Major Depressive Disorder and Dysthymic Disorder in Patients With Comorbid Alcohol Use Disorders: A Meta-Analysis of Placebo-Controlled Randomized Trials PDF quantity
$ 40.00
×
A Case of Agranulocytosis Secondary to Rechallenge With Clozapine Following Severe Neutropenia During Previous Therapy PDF
$ 40.00
A Case of Agranulocytosis Secondary to Rechallenge With Clozapine Following Severe Neutropenia During Previous Therapy PDF quantity
$ 40.00
×
Depression Plays a Moderating Role in the Cognitive Decline Associated With Changes of Brain White Matter Hyperintensities PDF
$ 40.00
Depression Plays a Moderating Role in the Cognitive Decline Associated With Changes of Brain White Matter Hyperintensities PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart